| Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology A Capuano, A De Corato, L Lisi, G Tringali, P Navarra, CD Russo Molecular Pain 5, 1744-8069-5-43, 2009 | 214 | 2009 |
| Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma L Lisi, GMP Ciotti, D Braun, S Kalinin, D Curro, CD Russo, A Coli, ... Neuroscience letters 645, 106-112, 2017 | 205 | 2017 |
| Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation CD Russo, L Lisi, G Tringali, P Navarra Biochemical pharmacology 78 (9), 1242-1251, 2009 | 185 | 2009 |
| The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1 SX Lin, L Lisi, CD Russo, PE Polak, A Sharp, G Weinberg, S Kalinin, ... ASN neuro 3 (2), AN20100033, 2011 | 177 | 2011 |
| mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis C Dello Russo, L Lisi, DL Feinstein, P Navarra Glia 61 (3), 301-311, 2013 | 112 | 2013 |
| Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized … L Lisi, E Stigliano, L Lauriola, P Navarra, CD Russo SAGE Publications 6 (3), AN20130045, 2014 | 90 | 2014 |
| The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes L Lisi, P Navarra, DL Feinstein, C Dello Russo Journal of neuroinflammation 8, 1-11, 2011 | 90 | 2011 |
| mTOR kinase: a possible pharmacological target in the management of chronic pain L Lisi, P Aceto, P Navarra, C Dello Russo BioMed Research International 2015 (1), 394257, 2015 | 73 | 2015 |
| Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis L Lisi, P Navarra, R Cirocchi, A Sharp, E Stigliano, DL Feinstein, ... Journal of neuroimmunology 243 (1-2), 43-51, 2012 | 72 | 2012 |
| The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype L Lisi, E Laudati, P Navarra, C Dello Russo Journal of Neuroinflammation 11, 1-10, 2014 | 66 | 2014 |
| Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the … L Lisi, PM Lacal, M Martire, P Navarra, G Graziani Pharmacological Research 175, 105997, 2022 | 63 | 2022 |
| Expression of the Glioma-Associated Oncogene Homolog 1 (Gli1) in Advanced Serous Ovarian Cancer Is Associated with Unfavorable Overall Survival G Ciucci, de Stefano, Vellone, Bottoni Scambia Plos One, 2013 | 63 | 2013 |
| Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm E Laudati, D Currò, P Navarra, L Lisi Neurochemistry international 108, 100-108, 2017 | 59 | 2017 |
| Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects A De Corato, L Lisi, A Capuano, G Tringali, A Tramutola, P Navarra, ... Journal of Neuroimmunology 237 (1-2), 39-46, 2011 | 59 | 2011 |
| Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells F Romani, A Tropea, E Scarinci, A Federico, CD Russo, L Lisi, S Catino, ... Fertility and sterility 102 (3), 831-837, 2014 | 57 | 2014 |
| Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections G De Pascale, L Lisi, GMP Ciotti, MS Vallecoccia, SL Cutuli, L Cascarano, ... Annals of Intensive Care 10, 1-9, 2020 | 51 | 2020 |
| Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers A Ciucci, GF Zannoni, M Buttarelli, L Lisi, D Travaglia, E Martinelli, ... Oncotarget 7 (7), 8155, 2016 | 51 | 2016 |
| Exploiting microglial functions for the treatment of glioblastoma C Dello Russo, L Lisi, L Tentori, P Navarra, G Graziani, C K Combs Current cancer drug targets 17 (3), 267-281, 2017 | 49 | 2017 |
| The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells MG Atzori, L Tentori, F Ruffini, C Ceci, L Lisi, E Bonanno, M Scimeca, ... Journal of Experimental & Clinical Cancer Research 36, 1-15, 2017 | 47 | 2017 |
| Modulatory effects of the CCR5 antagonist maraviroc on microglial pro‐inflammatory activation elicited by gp120 L Lisi, A Tramutola, A De Luca, P Navarra, C Dello Russo Journal of neurochemistry 120 (1), 106-114, 2012 | 46 | 2012 |
